AI could predict which stomach cancer patients benefit from Pre-Surgery therapy

NCT ID NCT07401199

Recruiting now Diagnosis Sponsor: Qun Zhao Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is developing an artificial intelligence (AI) system to predict how well gastric cancer will respond to chemotherapy and immunotherapy given before surgery. Researchers will collect data from 2,000 patients with locally advanced gastric cancer. The AI will analyze standard CT scans and tissue samples to forecast if the tumor will completely disappear after treatment. If accurate, this tool could help doctors choose the best treatment for each patient.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Artificial intelligence system (DeepComp) analyzing CT images and pathology slides
What this could lead to: If successful, this AI tool could help doctors personalize treatment plans for gastric cancer patients, avoiding unnecessary side effects.
What could go wrong: This is an observational study to develop and validate the AI model, not a treatment trial. The AI may not be accurate enough for real-world use, and results are still early.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER (GC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC CANCER (GC) LOCALLY ADVANCED GASTRIC CANCER

Contacts and locations

Locations

Baoding Central Hospital
RECRUITING

Baoding, None Selected, 050011, China
Cangzhou People's Hospital
RECRUITING

Cangzhou, Hebei, 050011, China
Hengshui People's Hospital
RECRUITING

Hengshui, Hebei, 053099, China
Renmin Hospital of Wuhan University
RECRUITING

Wuhan, Hubei, 430065, China
Shijiazhuang People's Hospital
RECRUITING

Shijiazhuang, None Selected, 050011, China
The Fifth Affiliated Hospital of Anhui Medical University
RECRUITING

Fuyang, Anhui, 050011, China
The Second Affiliated Hospital of Xingtai Medical College
RECRUITING

Xingtai, Hebei, 050011, China
Yichang Central Hospital
RECRUITING

Yichang, Hubei, 448000, China
the Fourth Hospital of Hebei Medical University
RECRUITING

Shijiazhuang, None Selected, 050011, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.